Clinical Trials

Showing 101 - 120 of 449 trials
Title Investigatorsort icon Disease(s)
A Phase I Study of SNX-5422 plus Erlotinib in Patients with Lung Cancer that Has Grown on Erlotinib Therapy
[Protocol 13-035]
Riely, Gregory
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase II Study of Bortezomib in Patients with KRAS-Mutant Non-Small Cell Lung Cancer
[Protocol 12-222]
Riely, Gregory
  • Lung Cancer, Non-Small Cell
Phase I Study of PF-02341066 in People with Advanced Cancer
[Protocol 07-157]
Riely, Gregory
A Phase I/II Study of Crizotinib and STA-9090 in ALK-Positive Lung Cancers
[Protocol 12-015]
Riely, Gregory
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase II Study of GSK2118436 in Patients with Advanced Non-Small Cell Lung Cancer and BRAF Mutations
[Protocol 11-023]
Riely, Gregory
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase III Study of Everolimus versus Placebo in Patients with Neuroendocrine Tumors Originating in the Lungs or Gastrointestinal Tract: The RADIANT-4 Study
[Protocol 12-250]
Reidy-Lagunes, Diane
  • Lung Cancer
  • Upper Gastrointestinal
    • Neuroendocrine
A Study of Degarelix Before Prostatectomy in Patients with Intermediate- to High-Risk Prostate Cancer
[Protocol 11-182]
Rathkopf, Dana
  • Prostate Cancer
    • Localized Disease
A Phase IA/B Study of CC-115 in Castration-Resistant Prostate Cancer
[Protocol 12-080]
Rathkopf, Dana
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
A Phase III Study of Cabozantinib versus Prednisone in Metastatic Castration-Resistant Prostate Cancer after Prior Treatment
[Protocol 12-274]
Rathkopf, Dana
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
A Phase II Study of AUY922 in Patients with Myelofibrosis
[Protocol 12-076]
Rampal, Raajit
  • Hematology
    • Hematologic Disorders
    • Hematologic Malignancies
  • Leukemia
    • Myeloproliferative Neoplasm
Measuring Patient Satisfaction in Breast Surgery: Development and Validation of a Patient-Reported Outcomes Instrument
[Protocol 05-058]
Pusic, Andrea
  • Breast Cancer
  • Survivorship
Development and Validation of a New Patient-Reported Outcome Instrument on the Impact of Altered Facial Appearance Following Oncologic Head and Neck Resection and Reconstruction
[Protocol 07-098]
Pusic, Andrea
  • Head & Neck Cancer
  • Survivorship
Microvascular Reconstruction for Advanced-Stage Head and Neck Cancer Patients: A Prospective Analysis of Quality of Life and Symptom Relief
[Protocol 07-150]
Pusic, Andrea
  • Head & Neck Cancer
Quality of Life and Patient-Reported Outcomes After Breast Reconstruction Surgery
[Protocol 12-093]
Pusic, Andrea
  • Breast Cancer
  • Survivorship
Expanded Access of Prochymal Infusion for the Treatment of Pediatric Patients with Acute Refractory GVHD
[Protocol 09-072]
Prockop, Susan
  • Blood and Marrow Transplantation
    • Transplantation
A Phase I Study of Vemurafenib in Adolescents with Inoperable Stage IIIC/IV Melanoma with V600 BRAF Mutations
[Protocol 11-198]
Pratilas, Christine
  • Melanoma
A Phase II Study of Partial Breast Irradiation for Select Patients with Early Invasive or Noninvasive Breast Cancer
[Protocol 10-114]
Powell, Simon
  • Breast Cancer
A Phase I Study of LDE225 with Etoposide and Cisplatin for the Initial Treatment of Extensive Small Cell Lung Cancer
[Protocol 11-206]
Pietanza, M. Catherine
  • Lung Cancer
  • Lung Cancer, Small Cell
    • Other
A Phase II Study of Temozolomide Alone or with ABT-888 (Veliparib) in Patients with Relapsed or Refractory Small Cell Lung Cancer
[Protocol 12-021]
Pietanza, M. Catherine
  • Lung Cancer
  • Lung Cancer, Small Cell
    • Other
A Phase III Study of Etoposide/Platinum with and without Ipilimumab in Patients with Newly Diagnosed Advanced Small Cell Lung Cancer
[Protocol 12-202]
Pietanza, M. Catherine
  • Lung Cancer
  • Lung Cancer, Small Cell